Minerva Neurosciences Inc
NERV
$3.71+1.23%
Delayed · as of Sep 21, 2026, 11:31 AM ET
Mkt cap
$12.45M
EV/Sales
N/A
P/E ratio
N/A
FY2024 Revenue
N/A
EPS (H1 2026)
$-32.13
Gross Margin (FY2024)
N/A
Profit Margin (FY2024)
N/A
Beta
-0.39
Div yield
N/A
Sector
Healthcare
Minerva Neurosciences Inc (NERV) is a biotechnology company listed on US.
Latest reported NERV revenue for 2024-12-31 was $0. Net income was $1.4M. NERV currently screens at market cap $12.4M.
Use this NERV research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full NERV income, balance, and cash tables.
Minerva Neurosciences Inc (NERV) is a biotechnology company in the Healthcare sector.
Latest cached Minerva Neurosciences Inc (NERV) net income for Dec 31, 2024 was $1.4M. Statements: https://lician.com/financials/nerv
Minerva Neurosciences Inc (NERV) market capitalization is $12.4M on the latest cached snapshot.
Minerva Neurosciences Inc (NERV) cached previous close $3.66; day range $3.59 – $3.81; volume 20,311. Session quote: https://lician.com/quote/nerv
Minerva Neurosciences Inc (NERV) latest cached earnings event is "NERV earnings" on Aug 13, 2026. Earnings calendar: https://lician.com/earnings
The latest cached NERV filing is 8-K · Aug 7, 2026. Filings: https://lician.com/sec/nerv